Net Income

Money20/20 and The Digital Chamber unite, creating a powerful nexus between global finance and Washington to steer the future of digital asset regulation.

Grocery AI leader Afresh expands its platform from the fresh aisle to the entire store, promising to end system fragmentation and boost profits and sustainability.

A new Columbus program integrates trauma therapy and eating disorder care, offering a lifeline for patients with complex, interconnected conditions.

The sale of the Bayonne Energy Center to a grid optimization specialist highlights private equity's growing role in shaping the future of urban power grids.

Huntress launches new ESPM and ISPM tools, leveraging AI and a key acquisition to proactively harden endpoints and identities for businesses of all sizes.

A new partnership promises to end alert fatigue by turning existing observability data into evidence-based AI runtime security intelligence.

The FDA grants PolyPid a crucial $4.3 million fee waiver for its D-PLEX₁₀₀ drug, freeing up vital cash to accelerate its commercial launch.

An 80s pop hit's famous phone number is now a vital resource for cancer support, leveraging nostalgia to make help unforgettable for millions.

The fast-growing vet chain hits a major milestone, but its venture-backed model reveals both the future of pet care and the challenges of rapid growth.

Cybersecurity firm Mondoo is tackling alert fatigue with a new AI and expert-led service that moves beyond reporting to actively remediate security flaws.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

After regaining Nasdaq compliance, Incannex Healthcare is leveraging its $75M war chest to advance novel treatments for sleep apnea and anxiety.

Brazil's largest holding company announces a historic 11% profit increase, a 59% shareholder return, and massive payouts, all amid high interest rates.

As AI valuations soar and IPOs loom, one veteran wealth manager warns of a familiar pattern. Are we witnessing innovation or another dot-com-style bubble?

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

A new report reveals a stark divide: employers are bullish on growth and AI, but worker confidence is collapsing, putting future productivity at risk.

Two Toledo auto shop sales highlight why investors are flocking to necessity-based real estate, driven by stable income and powerful tax incentives.

In a major strategic move, HSBC appoints Cécile Ratcliffe as CEO of its Continental Europe arm to drive growth in corporate and institutional banking.

Backed by dialysis giants DaVita and U.S. Renal Care, a new startup licenses a first-in-class therapy to transform treatment for kidney patients.